Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115940587 | 11594058 | 7 | F | 20150507 | 20160921 | 20151005 | 20160928 | EXP | PHHY2013CA110326 | NOVARTIS | 66.73 | YR | M | Y | 0.00000 | 20160928 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115940587 | 11594058 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (EVERY 4 WEEKS) | 720 | MG | U | 21008 | 30 | MG | /month | ||||
| 115940587 | 11594058 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO (ONCE A MONTH) | 720 | MG | U | 21008 | 30 | MG | /month | ||||
| 115940587 | 11594058 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, QMO (ONCE A MONTH) | 720 | MG | U | 21008 | 40 | MG | /month | ||||
| 115940587 | 11594058 | 4 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD (ONCE DAILY) | U | 0 | 10 | MG | QD | ||||||
| 115940587 | 11594058 | 5 | C | BISOPROLOL | BISOPROLOL | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115940587 | 11594058 | 1 | Pancreatic neuroendocrine tumour |
| 115940587 | 11594058 | 4 | Pancreatic neuroendocrine tumour |
| 115940587 | 11594058 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115940587 | 11594058 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115940587 | 11594058 | Ascites | |
| 115940587 | 11594058 | Bile duct obstruction | |
| 115940587 | 11594058 | Biliary dilatation | |
| 115940587 | 11594058 | Blood pressure increased | |
| 115940587 | 11594058 | Blood pressure systolic increased | |
| 115940587 | 11594058 | Diarrhoea | |
| 115940587 | 11594058 | Gait disturbance | |
| 115940587 | 11594058 | Gastrointestinal wall thickening | |
| 115940587 | 11594058 | Haemangioma of bone | |
| 115940587 | 11594058 | Heart rate decreased | |
| 115940587 | 11594058 | Hepatic lesion | |
| 115940587 | 11594058 | Hydrocele | |
| 115940587 | 11594058 | Injection site mass | |
| 115940587 | 11594058 | Malignant neoplasm progression | |
| 115940587 | 11594058 | Metastases to liver | |
| 115940587 | 11594058 | Metastases to peritoneum | |
| 115940587 | 11594058 | Trigger finger | |
| 115940587 | 11594058 | Vein disorder | |
| 115940587 | 11594058 | Venous pressure increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115940587 | 11594058 | 1 | 20130917 | 20150702 | 0 | |
| 115940587 | 11594058 | 2 | 20150730 | 20150925 | 0 | |
| 115940587 | 11594058 | 3 | 20151028 | 0 | ||
| 115940587 | 11594058 | 4 | 201311 | 0 |